ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Urca Prime Renda Fundo DE Investimento Imobiliario - FII

Urca Prime Renda Fundo DE Investimento Imobiliario - FII (URPR11)

58.20
1.32
( 2.32% )
Updated: 15:39:38

Empower your portfolio: Real-time discussions and actionable trading ideas.

URPR11 News

Official News Only
0 articles were found

Discussion

View Full Feed
ducci1 ducci1 3 minutes ago
WOW There They Go!!
SPY
EyeInTheSky EyeInTheSky 4 minutes ago
"good news" is an understatement.
HLLK
ducci1 ducci1 4 minutes ago
Wagg 594C .54 ?
SPY
koolmc koolmc 4 minutes ago
sure buddy fyi get your eyes checked
QMMM
Gooddolphin Gooddolphin 4 minutes ago
What next NSAV?... As another week goes by.
NSAV
Huggy Bear Huggy Bear 4 minutes ago
That is also ... Correct. Unless Foote lied about trying to RS his pet scam again, which given his history of fabrications entirely plausible as well ...
HMBL
ktcougar ktcougar 4 minutes ago
It's been a beautiful week! Sold maybe 5% of my Jan. and April calls today. Had to take a little off lol. It's been a December to remember lol!
www.stockscores.com/chart.asp?TickerSymbol=ATOM&TimeRange=30&Interval=120&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=4
ATOM
gp22 gp22 4 minutes ago
.$SPCB: Israel Security crowd finding..May rip big in AHs. Thats the history of $SPCB
SPCB
CommodityCoverage CommodityCoverage 4 minutes ago
Joining Steve Darling from Proactive, First Phosphate's (PHOS.c FRSPF) CEO, John Passalacqua, detailed two major milestones, the first being the signing of two long-term offtake agreements with creditworthy partners marks a pivotal step in securing the future of the company's operations in Saguenay-
FRSPF
MoneyMaker111 MoneyMaker111 4 minutes ago
"FFIE is worth $100/share (January Effect)" -Sources

$FFIE
#FFIE
FFIE
rbl100 rbl100 5 minutes ago
FDA APPROVES FBIO cancer drug !!!!

FDA approves cosibelimab-ipdl for metastatic or locally advanced cutaneous squamous cell carcinoma

On December 13, 2024, the Food and Drug Administration approved cosibelimab-ipdl (Unloxcyt, Checkpoint Therapeutics, Inc.), a programme
FBIO
LoveItInBishop LoveItInBishop 5 minutes ago
SFHG 1.39
Carjockey2 Carjockey2 5 minutes ago
Really chapped arse!!

Imo

$HMB
HMB
marcis marcis 5 minutes ago
The big question is

How much under valued share price does these clingons need to have

Dudes your are dealing with a company of last years rev’s $360!million

Anyone poking to get cheaper is sick IMO
RDAR
cybldron cybldron 5 minutes ago
yup keep smoking mr no brain cells left
PHIL
Mark Mark 5 minutes ago
$SYRA .44, has a gap on the chart to .80
SYRA
AugustaFriends AugustaFriends 5 minutes ago
$WIMI might do next week; what $QSI has done this week run to $4 area -- just a hunch... take it or leave... lots of great plays all over the place.
QSI WIMI
TenKay TenKay 5 minutes ago
We still don’t know if FINRA will process one. They didn’t the last time they tried.
HMBL
ducci1 ducci1 5 minutes ago
Closed 593P .52! Take it! Vix Reverse !!
SPY
copytele copytele 5 minutes ago
FOLLOWED YOU !
LITM
ulmadi ulmadi 6 minutes ago
Absolutely wrong!
The lenders look very closely at what the investment will bring them. And they also look very closely at which products
the company wants to finance with it, what the market is like and how profitable the company can be.
And I see a lot of potential in PHIL.
PHIL
F14SVF24 F14SVF24 6 minutes ago
Your posts are getting longer and longer. Save your breath. Lies.
HMBL
Penny Stocks 2.0 Penny Stocks 2.0 6 minutes ago
Not concerned one bit, silver is coming. Strong stock, load up!!
HLLK
Tiger Money Tiger Money 6 minutes ago
Also his tweets with saylor from micro were interesting as well.  Money is backing kurl for sure as buying has been relentless 
KULR